Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
February 2013 Volume 29 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February 2013 Volume 29 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes

  • Authors:
    • Fu-Shin Chueh
    • Yung-Liang Chen
    • Shu-Chun Hsu
    • Jai-Sing Yang
    • Shu-Ching Hsueh
    • Bin-Chuan Ji
    • Hsu-Feng Lu
    • Jing-Gung Chung
  • View Affiliations / Copyright

    Affiliations: Departments of Health and Nutrition Biotechnology, Asia University, Taichung 413, Taiwan, R.O.C., Department of Medical Laboratory Science and Biotechnology, Yuanpei University, Hsinchu 300, Taiwan, R.O.C., Departments of Nutrition, China Medical University, Taichung 404, Taiwan, R.O.C., Departments of Pharmacology, China Medical University, Taichung 404, Taiwan, R.O.C., Department of Clinical Pathology, Cheng Hsin General Hospital, Taipei 112, Taiwan, R.O.C., Division of Chest Medicine, Department of Internal Medicine, Changhua Christian Hospital, Changhua 500, Taiwan, R.O.C., Department of Clinical Pathology, Cheng Hsin General Hospital, Taipei 112, Taiwan, R.O.C., Departments of Biological Science and Technology, China Medical University, Taichung 404, Taiwan, R.O.C.
  • Pages: 613-618
    |
    Published online on: December 7, 2012
       https://doi.org/10.3892/or.2012.2170
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Numerous studies have demonstrated that triptolide induces cell cycle arrest and apoptosis in human cancer cell lines. However, triptolide-induced DNA damage and inhibition of DNA repair gene expression in human skin cancer cells has not previously been reported. We sought the effects of triptolide on DNA damage and associated gene expression in A375.S2 human malignant melanoma cells in vitro. Comet assay, DAPI staining and DNA gel electrophoresis were used for examining DNA damage and results indicated that triptolide induced a longer DNA migration smear based on single cell electrophoresis and DNA condensation and damage occurred based on the examination of DAPI straining and DNA gel electrophoresis. The real-time PCR technique was used to examine DNA damage and repair gene expression (mRNA) and results indicated that triptolide led to a decrease in the ataxia telangiectasia mutated (ATM), ataxia-telangiectasia and Rad3-related (ATR), breast cancer 1, early onset (BRCA-1), p53, DNA-dependent serine/threonine protein kinase (DNA-PK) and O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression. Thus, these observations indicated that triptolide induced DNA damage and inhibited DNA damage and repair-associated gene expression (mRNA) that may be factors for triptolide-mediated inhibition of cell growth in vitro in A375.S2 cells.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Pang J, Assaad D, Breen D, et al: Extramammary Paget disease: review of patients seen in a non-melanoma skin cancer clinic. Curr Oncol. 17:43–45. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Martinez JC and Otley CC: The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin Proc. 76:1253–1265. 2001. View Article : Google Scholar : PubMed/NCBI

3 

Rigel DS: Epidemiology of melanoma. Semin Cutan Med Surg. 29:204–209. 2010. View Article : Google Scholar

4 

Berwick M: How do solar UV irradiance and smoking impact the diagnosis of second cancers after diagnosis of melanoma?: No answer yet. Dermatoendocrinology. 4:18–19. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Pfeifer GP and Besaratinia A: UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem Photobiol Sci. 11:90–97. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Aceituno-Madera P, Buendia-Eisman A, Olmo FJ, Jimenez-Moleon JJ and Serrano-Ortega S: Melanoma, altitude, and UV-B radiation. Actas Dermosifiliogr. 102:199–205. 2011.(In Spanish).

7 

Mathew A, Lindsley TA, Sheridan A, et al: Degraded mitochondrial DNA is a newly identified subtype of the damage associated molecular pattern (DAMP) family and possible trigger of neurodegeneration. J Alzheimers Dis. 30:617–627. 2012.

8 

Baltanas FC, Casafont I, Weruaga E, Alonso JR, Berciano MT and Lafarga M: Nucleolar disruption and cajal body disassembly are nuclear hallmarks of DNA damage-induced neurodegeneration in purkinje cells. Brain Pathol. 21:374–388. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Barzilai A: DNA damage, neuronal and glial cell death and neurodegeneration. Apoptosis. 15:1371–1381. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Engelmann D and Putzer BM: Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance. Drug Resist Updat. 13:119–131. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Ye Y, Xiao Y, Wang W, et al: Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death. Mol Cancer Res. 7:1984–1999. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Suganuma M, Kawabe T, Hori H, Funabiki T and Okamoto T: Sensitization of cancer cells to DNA damage-induced cell death by specific cell cycle G2 checkpoint abrogation. Cancer Res. 59:5887–5891. 1999.PubMed/NCBI

13 

Potter AJ and Rabinovitch PS: The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs. Mutat Res. 572:27–44. 2005. View Article : Google Scholar : PubMed/NCBI

14 

Friedmann B, Caplin M, Hartley JA and Hochhauser D: Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839). Clin Cancer Res. 10:6476–6486. 2004. View Article : Google Scholar : PubMed/NCBI

15 

Kerklaan PR, Bouter S, van Elburg PE and Mohn GR: Evaluation of the DNA repair host-mediated assay. II Presence of genotoxic factors in various organs of mice treated with chemotherapeutic agents. Mutat Res. 164:19–29. 1986.PubMed/NCBI

16 

Norin AJ and Goldschmidt EP: Effect of mutagens, chemotherapeutic agents and defects in DNA repair genes on recombination in F′ partial diploid Escherichia coli. Mutat Res. 59:15–26. 1979.PubMed/NCBI

17 

Hikim AP, Lue YH, Wang C, Reutrakul V, Sangsuwan R and Swerdloff RS: Posttesticular antifertility action of triptolide in the male rat: Evidence for severe impairment of cauda epididymal sperm ultrastructure. J Androl. 21:431–437. 2000.

18 

Zhou GS, Hu Z, Fang HT, et al: Biologic activity of triptolide in t(8;21) acute myeloid leukemia cells. Leuk Res. 35:214–218. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Mak DH, Schober WD, Chen W, et al: Triptolide induces cell death independent of cellular responses to imatinib in blast crisis chronic myelogenous leukemia cells including quiescent CD34+ primitive progenitor cells. Mol Cancer Ther. 8:2509–2516. 2009. View Article : Google Scholar

20 

Shi X, Jin Y, Cheng C, et al: Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Clin Cancer Res. 15:1686–1697. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Pigneux A, Mahon FX, Uhalde M, et al: Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells. Exp Hematol. 36:1648–1659. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Yao GH, Luan JF, Ye D, et al: Effects of triptolide on proliferation and apoptosis of Jurkat cell line in acute T lymphocytic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 16:506–509. 2008.(In Chinese).

23 

Tong X, Zheng S, Jin J, Zhu L, Lou Y and Yao H: Triptolide inhibits cyclooxygenase-2 and inducible nitric oxide synthase expression in human colon cancer and leukemia cells. Acta Biochim Biophys Sin. 39:89–95. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Lou YJ and Jin J: Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells. Leuk Lymphoma. 45:373–376. 2004. View Article : Google Scholar : PubMed/NCBI

25 

Chan EW, Cheng SC, Sin FW and Xie Y: Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines. Toxicol Lett. 122:81–87. 2001. View Article : Google Scholar : PubMed/NCBI

26 

Liu J, Shen M, Yue Z, et al: Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21. Phytomedicine. 19:756–762. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Liu Y, Song F, Wu WK, et al: Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon. Cell Biochem Funct. 30:271–278. 2012. View Article : Google Scholar : PubMed/NCBI

28 

Kim MJ, Lee TH, Kim SH, Choi YJ, Heo J and Kim YH: Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway. Int J Oncol. 37:1177–1185. 2010.PubMed/NCBI

29 

Zhang C, Cui GH, Liu F, Wu QL and Chen Y: Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro. Acta Pharmacol Sin. 27:1438–1446. 2006. View Article : Google Scholar : PubMed/NCBI

30 

Yang S, Chen J, Guo Z, et al: Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther. 2:65–72. 2003.PubMed/NCBI

31 

Hsiao YP, Yu CS, Yu CC, et al: Triggering apoptotic death of human malignant melanoma a375. S2 cells by bufalin: involvement of caspase cascade-dependent and independent mitochondrial signaling pathways. Evid Based Complement Alternat Med. 2012:5912412012. View Article : Google Scholar

32 

Lo C, Lai TY, Yang JS, et al: Gallic acid inhibits the migration and invasion of A375. S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras. Melanoma Res. 21:267–273. 2011. View Article : Google Scholar : PubMed/NCBI

33 

Yu CS, Huang AC, Yang JS, et al: Safrole induces G0/G1 phase arrest via inhibition of cyclin E and provokes apoptosis through endoplasmic reticulum stress and mitochondrion-dependent pathways in human leukemia HL-60 cells. Anticancer Res. 32:1671–1679. 2012.

34 

Liu KC, Ho HC, Huang AC, et al: Gallic acid provokes DNA damage and suppresses DNA repair gene expression in human prostate cancer PC-3 cells. Environ Toxicol. Sept 2–2011.(Epub ahead of print).

35 

Ni CH, Yu CS, Lu HF, et al: Chrysophanol-induced cell death (necrosis) in human lung cancer A549 cells is mediated through increasing reactive oxygen species and decreasing the level of mitochondrial membrane potential. Environ Toxicol. Jul 30–2012.(Epub ahead of print).

36 

Yu CC, Ko FY, Yu CS, et al: Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells. Int J Oncol. 41:1050–1060. 2012.

37 

Ni CH, Chen PY, Lu HF, et al: Chrysophanol-induced necrotic-like cell death through an impaired mitochondrial ATP synthesis in Hep3B human liver cancer cells. Arch Pharm Res. 35:887–895. 2012. View Article : Google Scholar : PubMed/NCBI

38 

Tsai SC, Yang JS, Peng SF, et al: Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells. Int J Oncol. 41:1431–1442. 2012.PubMed/NCBI

39 

Chen HY, Lu HF, Yang JS, et al: The novel quinolone CHM-1 induces DNA damage and inhibits DNA repair gene expressions in a human osterogenic sarcoma cell line. Anticancer Res. 30:4187–4192. 2010.PubMed/NCBI

40 

Lin YT, Yang JS, Lin SY, et al: Diallyl disulfide (DADS) induces apoptosis in human cervical cancer Ca Ski cells via reactive oxygen species and Ca2+-dependent mitochondria-dependent pathway. Anticancer Res. 28:2791–2799. 2008.PubMed/NCBI

41 

Chen YY, Chiang SY, Lin JG, et al: Emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 human tongue cancer cells. Anticancer Res. 30:945–951. 2010.PubMed/NCBI

42 

Ho YT, Lu CC, Yang JS, et al: Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. Anticancer Res. 29:4063–4070. 2009.

43 

Lu HF, Yang JS, Lai KC, et al: Curcumin-induced DNA damage and inhibited DNA repair genes expressions in mouse-rat hybrid retina ganglion cells (N18). Neurochem Res. 34:1491–1497. 2009. View Article : Google Scholar : PubMed/NCBI

44 

Ji BC, Yu CC, Yang ST, et al: Induction of DNA damage by deguelin is mediated through reducing DNA repair genes in human non-small cell lung cancer NCI-H460 cells. Oncol Rep. 27:959–964. 2012.PubMed/NCBI

45 

Wu PP, Liu KC, Huang WW, et al: Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway. Oncol Rep. 25:551–557. 2011.PubMed/NCBI

46 

Huang W, He T, Chai C, et al: Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression. PLoS One. 7:e376932012. View Article : Google Scholar : PubMed/NCBI

47 

Petriccione M and Ciniglia C: Comet assay to assess the genotoxicity of Persian walnut (Juglans regia L.) husks with statistical evaluation. Bull Environ Contam Toxicol. 89:166–171. 2012. View Article : Google Scholar : PubMed/NCBI

48 

Kwasniewska J, Grabowska M, Kwasniewski M and Kolano B: Comet-FISH with rDNA probes for the analysis of mutagen-induced DNA damage in plant cells. Environ Mol Mutagen. 53:369–375. 2012. View Article : Google Scholar : PubMed/NCBI

49 

Goutham HV, Mumbrekar KD, Vadhiraja BM, et al: DNA double-strand break analysis by γ-H2AX foci: A useful method for determining the overreactors to radiation-induced acute reactions among head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. Jul 24–2012.(Epub ahead of print).

50 

Savina NV, Smal MP, Kuzhir TD, Ershova-Pavlova AA and Goncharova RI: DNA-damage response associated with occupational exposure, age and chronic inflammation in workers in the automotive industry. Mutat Res. 748:21–28. 2012. View Article : Google Scholar : PubMed/NCBI

51 

Pennington KP, Walsh T, Lee M, et al: BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Cancer. Jul 18–2012.(Epub ahead of print).

52 

Serrano MA, Li Z, Dangeti M, et al: DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to facilitate homologous recombination DNA repair. Oncogene. Jul 16–2012.(Epub ahead of print).

53 

Fortini P, Ferretti C, Pascucci B, et al: DNA damage response by single-strand breaks in terminally differentiated muscle cells and the control of muscle integrity. Cell Death Differ. Jun 15–2012.(Epub ahead of print).

54 

Jia YG, Yang YM, Zuo B, Guo LD and Lou JY: DNA damage response in ovarian clear cell adenocarcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban. 43:331–334. 2012.(In Chinese).

55 

Wong VC, Cash HL, Morse JL, Lu S and Zhitkovich A: S-phase sensing of DNA-protein crosslinks triggers TopBP1-independent ATR activation and p53-mediated cell death by formaldehyde. Cell Cycle. 11:2526–2537. 2012. View Article : Google Scholar : PubMed/NCBI

56 

Boltz KA, Leehy K, Song X, Nelson AD and Shippen DE: ATR cooperates with CTC1 and STN1 to maintain telomeres and genome integrity in Arabidopsis. Mol Biol Cell. 23:1558–1568. 2012. View Article : Google Scholar : PubMed/NCBI

57 

Tammaro C, Raponi M, Wilson DI and Baralle D: BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer. Biochem Soc Trans. 40:768–772. 2012. View Article : Google Scholar : PubMed/NCBI

58 

Pessetto ZY, Yan Y, Bessho T and Natarajan A: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option. Breast Cancer Res Treat. 134:511–517. 2012. View Article : Google Scholar

59 

Yarden RI, Metsuyanim S, Pickholtz I, Shabbeer S, Tellio H and Papa MZ: BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrest. Int J Biochem Cell Biol. 44:1761–1769. 2012. View Article : Google Scholar : PubMed/NCBI

60 

Silber JR, Bobola MS, Blank A and Chamberlain MC: O(6)-Methylguanine-DNA methyltransferase in glioma therapy: Promise and problems. Biochim Biophys Acta. 1826:71–82. 2012.PubMed/NCBI

61 

Fumagalli C, Pruneri G, Possanzini P, et al: Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients. Breast Cancer Res Treat. 134:131–137. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chueh F, Chen Y, Hsu S, Yang J, Hsueh S, Ji B, Lu H and Chung J: Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes. Oncol Rep 29: 613-618, 2013.
APA
Chueh, F., Chen, Y., Hsu, S., Yang, J., Hsueh, S., Ji, B. ... Chung, J. (2013). Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes. Oncology Reports, 29, 613-618. https://doi.org/10.3892/or.2012.2170
MLA
Chueh, F., Chen, Y., Hsu, S., Yang, J., Hsueh, S., Ji, B., Lu, H., Chung, J."Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes". Oncology Reports 29.2 (2013): 613-618.
Chicago
Chueh, F., Chen, Y., Hsu, S., Yang, J., Hsueh, S., Ji, B., Lu, H., Chung, J."Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes". Oncology Reports 29, no. 2 (2013): 613-618. https://doi.org/10.3892/or.2012.2170
Copy and paste a formatted citation
x
Spandidos Publications style
Chueh F, Chen Y, Hsu S, Yang J, Hsueh S, Ji B, Lu H and Chung J: Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes. Oncol Rep 29: 613-618, 2013.
APA
Chueh, F., Chen, Y., Hsu, S., Yang, J., Hsueh, S., Ji, B. ... Chung, J. (2013). Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes. Oncology Reports, 29, 613-618. https://doi.org/10.3892/or.2012.2170
MLA
Chueh, F., Chen, Y., Hsu, S., Yang, J., Hsueh, S., Ji, B., Lu, H., Chung, J."Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes". Oncology Reports 29.2 (2013): 613-618.
Chicago
Chueh, F., Chen, Y., Hsu, S., Yang, J., Hsueh, S., Ji, B., Lu, H., Chung, J."Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes". Oncology Reports 29, no. 2 (2013): 613-618. https://doi.org/10.3892/or.2012.2170
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team